Y-box binding protein 1: Providing a new angle on translational regulation

Cell Cycle

Volumn 5, Issue 11, 2006, Pages 1143-1147

  Evdokimova, Valentina ^a,b,c   Ovchinnikov, Lev P ^c   Sorensen, Poul H B ^a,b  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b BRITISH COLUMBIA CANCER RESEARCH CENTRE   (Canada)

^c INSTITUTE OF PROTEIN RESEARCH   (Russian Federation)

Author keywords

Akt PKB; Cap dependent translation; eIF4E; Inactive mRNPs; Phosphorylation; Polyribosornes; Regulation; YB 1

Indexed keywords

CAP BINDING PROTEIN; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN ELF4E; PROTEIN KINASE B; RAS PROTEIN; REGULATOR PROTEIN; SERINE; UNCLASSIFIED DRUG; Y BOX BINDING PROTEIN 1;

5' UNTRANSLATED REGION; CELL ACTIVATION; CELL GROWTH; CELL VIABILITY; EUKARYOTE; NONHUMAN; PROTEIN BINDING; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; REVIEW; RIBOSOME; SIGNAL TRANSDUCTION;

EUKARYOTA;

EID: 33744908818     PISSN: 15384101     EISSN: 15514005     Source Type: Journal    
DOI: 10.4161/cc.5.11.2784     Document Type: Review

References (29)

1. Spirin AS. On "masked" forms of messenger RNA in early embryogenesis and in other differentiating systems. Curr Top Dev Biol 1966; 1:1-63.
2. Sonenberg N. mRNA 5′ cap-binding protein eIF4E and control of cell growth. In: Hershey JWB, Mathews MB, Sonenberg N, eds. Translational Control. Cold Spring Harbor Laboratory Press, 1996:245-69.
3. Lazaris-Karatzas A, Montine KS, Sonenberg N. Malignant transformation by a eukaryotic initiation factor subunit that binds to mRNA 5′ cap. Nature 1990; 345:544-7.
4. Koromilas AE, Lazaris-Karatzas A, Sonenberg N. mRNAs containing extensive secondary structure in their 5′ noncoding region translate efficiently in cells overexpressing initiation factor eIF-4E. EMBO J 1992; 11:4153-8.
5. Rosenwald IB, Lazaris-Karatzas A, Sonenberg N, Schmidt EV. Elevated levels of cyclin D1 protein in response to increased expression of eukaryotic initiation factor 4E. Mol Cell Biol 1993; 13:7358-63.
6. Kevil C, Carter P, Hu B, DeBenedetti A. Translational enhancement of FGF-2 by eIF-4 factors, and alternate utilization of CUG and AUG codons for translation initiation. Oncogene 1995; 11:2339-48.
7. Rousseau D, Kaspar R, Rosenwald I, Gehrke L, Sonenberg N. Translation initiation of ornithine decarboxylase and nucleocytoplasmic transport of cyclin D1 mRNA are increased in cells overexpressing eukaryotic initiation factor 4E. Proc Natl Acad Sci USA 1996; 93:1065-70.
8. Kevil CG, De Benedetti A, Payne DK, Coe LL, Laroux FS, Alexander JS. Translational regulation of vascular permeability factor by eukaryotic initiation factor 4E: Implications for tumor angiogenesis. Int J Cancer 1996; 65:785-90.
9. Montanaro L, Pandolfi PP. Initiation of mRNA translation in oncogenesis: The role of eIF4E. Cell Cycle 2004; 3:1387-9.
10. Mamane Y, Petroulakis E, Rong L, Yoshida K, Ler LW, Sonenberg N. eIF4E - from translation to transformation. Oncogene 2004; 23:3172-9.
11. Wendel HG, Lowe SW. Reversing drug resistance in vivo. Cell Cycle 2004; 3:847-9.
12. Matsumoto K, Wolffe A. Gene regulation by Y-box proteins: Coupling control of transcription and translation. Trends Cell Biol 1998; 8:318-23.
13. Kuwano M, Uchiumi T, Hayakawa H, Ono M, Wada M, Izumi H, Kohno K. The basic and clinical implications of ABC transporters, Y-box-binding protein-1 (YB-1) and angio-genesis-related factors in human malignancies. Cancer Sci 2003; 94:9-14.
14. Evdokimova VM, Ovchinnikov LP. Translational regulation by Y-box transcription factor: Involvement of the major mRNA-associated protein, p50. Int J Biochem Cell Biol 1999; 31:139-49.
15. Sommerville J, Ladomery M. Transcription and masking of mRNA in germ cells: Involvement of Y-box proteins. Chromosoma 1996; 104:469-78.
16. Gualerzi CO, Giuliodori AM, Pon CL. Transcriptional and post-transcriptional control of cold-shock genes. J Mol Biol 2003; 331:527-39.
17. Evdokimova VM, Ruzanov P, Imataka H, Raught B, Svitkin Y, Ovchinnikov LP, Sonenberg N. The major mRNA-associated protein YB-1 is a potent 5′ cap-dependent mRNA stabilizer. EMBO J 2001; 20:5491-502.
18. Nekrasov MP, Ivshina MP, Chernov KG, Kovrigina EA, Evdokimova VM, Thomas AA, Hershey JW, Ovchinnikov LP. The mRNA-binding protein YB-1 (p50) prevents association of the eukaryotic initiation factor eIF4G with mRNA and inhibits protein synthesis at the initiation stage. J Biol Chem 2003; 278:13936-43.
19. Evdokimova V, Ruzanov P, Anglesio MS, Sorokin A, Ovchinnikov L, Buckley J, Triche TJ, Sonenberg N, Sorensen PHB. Akt-mediated YB-1 phosphorylation activates translation of silent mRNA species. Mol Cell Biol 2006; 26:277-91.
20. Sutherland BW, Kucab J, Wu J, Lee C, Cheang MC, Yorida E, Turbin D, Dedhar S, Nelson C, Pollak M, Leighton Grimes H, Miller K, Badve S, Huntsman D, Blake-Gilks C, Chen M, Pallen CJ, Dunn SE. Akt phosphorylates the Y-box binding protein 1 at Ser102 located in the cold shock domain and affects the anchorage-independent growth of breast cancer cells. Oncogene 2005; 24:4281-92.
21. Ruggero D, Sonenberg N. The Akt of translational control. Oncogene 2005; 24:7426-34.
22. Rajasekhar VK, Viale A, Socci ND, Wiedmann M, Hu X, Holland EC. Oncogenic Ras and Akt signaling contribute to glioblastoma formation by differential recruitment of existing mRNAs to polysomes. Mol Cell 2003; 12:889-901.
23. Capowski EE, Esnault S, Bhattacharya S, Malter JS. Y box-binding factor promotes eosinophil survival by stabilizing granulocyte-macrophage colony-stimulating factor mRNA. J Immunology 2001; 167:5970-6.
24. Coles LS, Bartley MA, Bert A, Hunter J, Polyak S, Diamond P, Vadas MA, Goodall GJ. A multi-protein complex containing cold shock domain (Y-box) and polypyrimidine tract binding proteins forms on the vascular endothelial growth factor mRNA. Potential role in mRNA stabilization. Eur J Biochem 2004; 271:648-60.
25. Tognon C, Garnett M, Kenward E, Kay R, Morrison K, Sorensen PH. The chimeric protein tyrosine kinase ETV6-NTRK3 requires both Ras-Erk1/2 and PI3-kinase-Akt signaling for fibroblast transformation. Cancer Res 2001; 15:8909-16.
26. Lannon CL, Sorensen PH. ETV6-NTRK3: A chimeric protein tyrosine kinase with transformation activity in multiple cell lineages. Semin Cancer Biol 2005; 15:215-23.
27. Zong Q, Schummer M, Hood L, Morris DR. Messenger RNA translation state: The second dimension of high-throughput expression screening. Proc Natl Acad Sci USA 1999; 96:10632-6.
28. Mikulits W, Pradet-Balade B, Habermann B, Beug H, Garcia-Sanz JA, Mullner EW. Isolation of translationally controlled mRNAs by differential screening. FASEB J 2000; 14:1641-52.
29. Rajasekhar VK, Holland EC. Postgenomic global analysis of translational control induced by oncogenic signaling. Oncogene 2004; 23:3248-64.